Cargando…

Unleashing the power of anti-tumor CD4+ T cells: novel insights into the curative mechanisms of chemoimmunotherapy for cancer

Detalles Bibliográficos
Autores principales:	Habtetsion, Tsadik G, Zhou, Gang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4645558/ http://dx.doi.org/10.1186/2051-1426-3-S2-P18

Ejemplares similares

Exploiting metabolic inhibition to eradicate residual tumors after chemo-immunotherapy
por: Habtetsion, Tsadik, et al.
Publicado: (2014)

The impact of antibiotic usage on the efficacy of chemoimmunotherapy is contingent on the source of tumor-reactive T cells
por: Kuczma, Michal P., et al.
Publicado: (2017)

Focused ultrasound: an effective technique for unleashing the power of immunotherapy in the tumor microenvironment?
por: Repasky, Elizabeth
Publicado: (2015)

Generation and utilization of polyfunctional anti-tumor CD4+ T cells
por: Zhou, Gang, et al.
Publicado: (2015)

Combination chemoimmunotherapy with monthly cycles of 5-fluorouracil + interferon-alfa-2b in previously-treated advanced cancer
por: Quan, Walter, et al.
Publicado: (2013)

Upregulation of neuroreceptors on CD4+ and CD8+ T cells promotes their anti-tumor function
por: de Aquino, Maria Teresa, et al.
Publicado: (2015)

The mechanism of anti-tumor immunity induced by varlilumab, a CD27 agonist mAb, is model dependent
por: He, Li-Zhen, et al.
Publicado: (2015)

Mcl-1 expression influcences CD8+ anti-tumor immunity.
por: Pfannenstiel, Lukas W, et al.
Publicado: (2015)

Unleash the Power of Paid Search
por: Mitchell, Melanie
Publicado: (2012)

Microsoft PowerShell unleashed
por: Kopczynski, Tyson
Publicado: (2007)

Windows PowerShell unleashed
por: Kopczynski, Tyson, et al.
Publicado: (2009)

Detection of antibody therapy-induced anti-tumor immune responses using anti-CD8 immuno-pet
por: Tavare, Richard, et al.
Publicado: (2015)

Costimulatory T cell engagement via a novel bispecific anti-CD137 /anti-HER2 protein
por: Hinner, Marlon J, et al.
Publicado: (2015)

Combination immunotherapy with anti-CTLA-4 and interleukin-2 redirects regulatory T cells into tumor-draining lymph nodes and expands anti-tumor CD8+ T cells in the tumor microenvironment
por: Broucek, Joseph, et al.
Publicado: (2014)

The human CD40 agonistic antibody ADC-1013 generates immune mediated anti-tumor effects in syngeneic tumor models in hCD40 transgenic mice
por: Mangsbo, Sara M, et al.
Publicado: (2014)

Combination therapies augment the anti-tumor activity of agonist CD27 mAb in human CD27 transgenic mouse models
por: He, Li-Zhen, et al.
Publicado: (2013)

Tumor Vaccines: Unleashing the Power of the Immune System to Fight Cancer
por: Liu, Dequan, et al.
Publicado: (2023)

The Power of Telehealth Has Been Unleashed
por: Wang, C. Jason, et al.
Publicado: (2020)

The signalling signature downstream of the notch receptor in CD4(+)CD25(high )regulatory T cells in RA defines anergic cells: insight into resistance to anti-tumour necrosis factor therapies
por: Buch, MH, et al.
Publicado: (2005)

Novel antitumor mechanism-of-action of an IL-2 fusion protein mediated by tumor associated macrophage repolarization and innate-like CD8+ memory T cells
por: Xu, Wenxin, et al.
Publicado: (2014)

PD-1 blockade reverses viral infection-induced loss of anti-tumor CD8+ T cell responses
por: Huelsmann, Erica, et al.
Publicado: (2013)

Acute viral infection results in a PD-1-dependent loss of anti-tumor CD8+ T cell responses: implications for tumor immunotherapy
por: Kohlhapp, Frederick, et al.
Publicado: (2015)

P135: THE CLINGEN HEMOGLOBINOPATHY VARIANT CURATION EXPERT PANEL
por: Coralea Stephanou, C, et al.
Publicado: (2022)

CXCR5+CD8+ T cells are localized in B cell follicles and germinal centers and exhibit regulatory and anti-tumor function
por: Chu, Fuliang, et al.
Publicado: (2015)

High frequency CD8+PD-1+ TCR clonotypes isolated from fresh melanomas display anti-tumor activity
por: Anna, Pasetto, et al.
Publicado: (2015)

Bystander memory CD8 T cell proliferation after anti-CD40/IL-2 treatment is independent of CD4 T cells
por: Grossenbacher, Steven K, et al.
Publicado: (2013)

Treatment of B cells malignancies with anti-CD19 CAR+, TCR-, CD52- allogeneic T cells
por: Mannioui, Cécile Schiffer, et al.
Publicado: (2013)

Think to Win: Unleashing the Power of Strategic Thinking
por: Butler, Paul
Publicado: (2015)

Digital crowdsourcing: unleashing its power in rheumatology
por: Krusche, Martin, et al.
Publicado: (2020)

Unleashing the power of NK cells in anticancer immunotherapy
por: Vogler, Meike, et al.
Publicado: (2021)

Unleashing the Power of Artificial Intelligence in Materials Design
por: Badini, Silvia, et al.
Publicado: (2023)

Tumor derived exosome induction of the CD3+CD8+ T cell tolerogenic phenotype
por: Maybruck, Brian, et al.
Publicado: (2013)

IL-12 primed CD8+ T-cells possess enhanced persistence and anti-tumor efficacy because of greater IL-7 responsiveness
por: Johnson, C Bryce, et al.
Publicado: (2013)

Whole body irradiation and agonist anti-CD40 synergize to promote adoptive T cell therapy of resistant murine pancreatic neuroendocrine tumors
por: Ward-Kavanagh, Lindsay, et al.
Publicado: (2015)

Revolutionizing anti-tumor therapy: unleashing the potential of B cell-derived exosomes
por: Xiong, Jingwen, et al.
Publicado: (2023)

Novel synthetic RORγ agonist compounds as a potential anti-tumor therapeutic approach
por: Hu, Xiao, et al.
Publicado: (2014)

Innate and adaptive immunity contribute to the anti-tumor mechanisms of action of OncoVEX(mGM-CSF)
por: Cooke, Keegan, et al.
Publicado: (2015)

Adjuvant IL-7 potentiates adoptive T cell therapy by amplifying and sustaining polyfunctional antitumor CD4+ T cells
por: Ding, Zhi-Chun, et al.
Publicado: (2017)

Anti-tumor effects of anti-PD-L1 therapy in an orthotopic bladder tumor model
por: Lyon, Amanda, et al.
Publicado: (2014)

Immunotargeting of tumor vasculature: preclinical development of novel antibody-based imaging and therapy against TEM1/CD248
por: Li, Chunsheng, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_362v8kel34pmcjip6mu8f43bbr